Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Kamal Sahni"'
Autor:
Smriti Srivastava, Madhup Rastogi, Ajeet Gandhi, Rohini Khurana, Rahat Hadi, Shantanu Sapru, Anoop Srivastava, Avinav Bharati, Nuzhat Husain, Surendra Mishra, Kamal Sahni
Publikováno v:
Contemporary Oncology, Vol 26, Iss 3, Pp 180-186 (2022)
Externí odkaz:
https://doaj.org/article/dc145f88b96540b0af18ee2c363d68c5
Autor:
Mohammad Ali, Kamal Sahni, Shantanu Sapru, Madhup Rastogi, Rohini Khurana, Rahat Hadi, Ajeet Kumar Gandhi, Sambit Swarup Nanda
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 12, Pp 10-15 (2021)
Introduction: Conventional Whole Pelvic Radiotherapy (WPRT) is associated with significant morbidity, especially haematological and Gastrointestinal (GI), which increases further with concurrent chemotherapy. Various studies have shown a clinical
Externí odkaz:
https://doaj.org/article/65eef926e45441d9ae4e82d246505d05
Autor:
Harikesh Singh, Ajeet Gandhi, Shantanu Sapru, Rohini Khurana, Rahat Hadi, Sambit Nanda, Satyajeet Rath, Avinav Bharati, Anoop Srivastava, Surendera Mishra, Kamal Sahni, Nuzhat Husain, Madhup Rastogi
Publikováno v:
Iranian Journal of Medical Physics, Vol 16, Iss 5, Pp 385-391 (2019)
Introduction: We aimed to dosimetrically compare three-dimensional conformal radiotherapy (3D-CRT) and volumetric modulated arc therapy (VMAT) in terms of planning target volume (PTV) coverage, organ at risk (OAR) sparing, and conformity index (CI).
Externí odkaz:
https://doaj.org/article/2b01dc89c89f4e21bbc1b1d159d7e016
Autor:
Rohini Khurana, NarayanPratap Singh, Shantanu Sapru, Madhup Rastogi, AjeetKumar Gandhi, Satyajeet Rath, Rahat Hadi, SurendraPrasad Mishra, AnoopKumar Srivastava, Avinav Bharti, Kamal Sahni, Mohammad Ali, Ramakant Tiwari
Publikováno v:
Journal of cancer research and therapeutics. 18(6)
To evaluate efficacy and late toxicity of intensity-modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) in definitive management of head-and-neck cancers.In this prospective interventional study, histological proven squamous cell car
Autor:
Kamal Sahni, A. Bharati, Rahat Hadi, Ajeet Kumar Gandhi, Satyajeet Rath, Madhup Rastogi, S. Sapru, Animesh Agrawal, Surendra Prasad Mishra, Rohini Khurana, Anoop Kumar Srivastava
Publikováno v:
Journal of Radiotherapy in Practice. 21:60-67
Introduction:Dosimetric advantages of volumetric-modulated arc therapy (VMAT) over three-dimensional conformal radiotherapy (3D-CRT) are not established in a head-on comparison of a uniform group of locally advanced carcinoma of the cervix (LACC). Th
Publikováno v:
Journal of Cancer Research and Therapeutics.
Autor:
Rahat Hadi, Anoop Kumar Srivastava, Farzana Syedkather, S. Sapru, Rohini Khurana, Satyajeet Rath, Madhup Rastogi, Ajeet Kumar Gandhi, Kamal Sahni, S.P. Mishra
Publikováno v:
Asia-Pacific Journal of Clinical Oncology. 16:14-22
OBJECTIVES Randomized controlled trials have shown improved loco-regional control (LRC) and disease-free survival (DFS) by modest acceleration using six fractions per-week radiotherapy (RT) as compared to conventional fractionation in patients of hea
Autor:
Narayan Pratap Singh, Sambit Swarup Nanda, Ajeet Kumar Gandhi, Kamal Sahni, S. Sapru, Madan Lal Brahma Bhatt, Rohini Khurana, Rahat Hadi, Ramakant Tiwari, Mohammad Ali, Madhup Rastogi
Background Various studies have shown a clinical benefit of pelvic IMRT but included a significant number of patients with intact cervix and uterus. Therefore we proposed a prospective study to evaluate the toxicity, feasibility, and tolerance of IMR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::900f6dc7bf9ed5f8db5e355e72ac2821
https://doi.org/10.21203/rs.3.rs-403138/v1
https://doi.org/10.21203/rs.3.rs-403138/v1
Autor:
S. Sapru, Rohini Khurana, S. Parida, Madhup Rastogi, Nuzhat Husain, S. Srivastava, Rahat Hadi, A. Bharati, Ajeet Kumar Gandhi, Kamal Sahni, Anoop Kumar Srivastava, S.P. Mishra
Publikováno v:
Radiotherapy and Oncology. 161:S826-S827
Publikováno v:
SRMS JOURNAL OF MEDICAL SCIENCE. 1:66-72
Introduction: Concurrent chemoradiation is the standard treatment for the locally advanced cervical cancer. The optimal Cisplatin dose and dosing schedule are still undetermined. The present study aims to evaluate the efficacy and toxicity of weekly